Literature DB >> 25839931

Predictors of sinonasal quality of life and nasal morbidity after fully endoscopic transsphenoidal surgery.

Andrew S Little1, Daniel Kelly, John Milligan1, Chester Griffiths, Daniel M Prevedello2, Ricardo L Carrau2, Gail Rosseau3, Garni Barkhoudarian, Bradley A Otto2, Heidi Jahnke1, Charlene Chaloner, Kathryn L Jelinek2, Kristina Chapple1, William L White1.   

Abstract

OBJECT: Despite the increasing application of endoscopic transsphenoidal surgery for pituitary lesions, the prognostic factors that are associated with sinonasal quality of life (QOL) and nasal morbidity are not well understood. The authors examine the predictors of sinonasal QOL and nasal morbidity in patients undergoing fully endoscopic transsphenoidal surgery.
METHODS: An exploratory post hoc analysis was conducted of patients who underwent endoscopic pituitary surgery and were enrolled in a prospective multicenter QOL study. End points of the study included patient-reported sinonasal QOL and objective nasal endoscopy findings. Multivariate models were developed to determine the patient and surgical factors that correlated with QOL at 2 weeks through 6 months after surgery.
RESULTS: This study is a retrospective review of a subgroup of patients studied in the clinical trial "Rhinological Outcomes in Endonasal Pituitary Surgery" (clinical trial no. NCT01504399, clinicaltrials.gov ). Data from 100 patients who underwent fully endoscopic transsphenoidal surgery were included. Predictors of a lower postoperative sinonasal QOL at 2 weeks were use of nasal splints (p = 0.039) and female sex at the trend level (p = 0.061); at 3 months, predictors of lower QOL were the presence of sinusitis (p = 0.025), advancing age (p = 0.044), and use of absorbable nasal packing (p = 0.014). Health status (multidimensional QOL) was also predictive at 2 weeks (p = 0.001) and 3 months (p < 0.001) and was the only significant predictor of sinonasal QOL at 6 months (p < 0.001). A Kaplan-Meier analysis was performed to study time to resolution of nasal crusting, mucopurulence, and synechia as observed during nasal endoscopy after surgery. The mean time (± SEM) to absence of nasal crusting was 16.3 ± 2.1 weeks, mucopurulence was 6.2 ± 1.1 weeks, and synechia was 4.4 ± 0.5 weeks. Use of absorbable nasal packing was associated with more severe mucopurulence.
CONCLUSIONS: Sinonasal QOL following endoscopic pituitary surgery reaches a nadir at 2 weeks and recovers by 3 months postoperatively. Use of absorbable packing and nasal splints, while used in a minority of patients, negatively correlates with early sinonasal QOL. Sinonasal QOL and overall health status are well correlated in the postoperative period, suggesting the important influence of sinonasal QOL on the patient experience.

Entities:  

Keywords:  ASK Nasal-12 = Anterior Skull Base Nasal Inventory-12; QOL = quality of life; SF-8 = 8-item Short-Form Health Survey; endoscopic surgery; pituitary adenoma; pituitary surgery; quality of life; sinusitis; transsphenoidal surgery

Mesh:

Year:  2015        PMID: 25839931     DOI: 10.3171/2014.10.JNS141624

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  16 in total

Review 1.  Resection of pituitary tumors: endoscopic versus microscopic.

Authors:  Harminder Singh; Walid I Essayed; Aaron Cohen-Gadol; Gabriel Zada; Theodore H Schwartz
Journal:  J Neurooncol       Date:  2016-05-09       Impact factor: 4.130

2.  Transient Exacerbation of Nasal Symptoms following Endoscopic Transsphenoidal Surgery for Pituitary Tumors: A Prospective Study.

Authors:  Benjamin M Davies; Erica Tirr; Yi Yuen Wang; Kanna K Gnanalingham
Journal:  J Neurol Surg B Skull Base       Date:  2017-01-23

3.  Impact of patient-reported nasal symptoms on quality of life after endoscopic pituitary surgery: a prospective cohort study.

Authors:  Wouter R van Furth; Amir H Zamanipoor Najafabadi; Merel van der Meulen; Marco J T Verstegen; Daniel J Lobatto; Maarten C Kleijwegt; Alberto M Pereira; Nienke R Biermasz
Journal:  Pituitary       Date:  2022-01-10       Impact factor: 4.107

4.  Sinonasal Symptoms and Self-Reported Health before and after Endoscopic Pituitary Surgery-A Prospective Study.

Authors:  Tobias Hallén; Daniel S Olsson; Dan Farahmand; Daniela Esposito; Ann-Charlotte Olofsson; Sofie Jakobsson; Eva Jakobsson Ung; Pernilla Sahlstrand-Johnson; Gudmundur Johannsson; Thomas Skoglund; Henrik Bergquist
Journal:  J Neurol Surg B Skull Base       Date:  2021-02-18

5.  Sinonasal Packing is Not a Requisite for Successful Cerebrospinal Fluid Leak Repair.

Authors:  Karam Asmaro; Frederick Yoo; Abdulkader Yassin-Kassab; Michael Bazydlo; Adam M Robin; Jack P Rock; John R Craig
Journal:  J Neurol Surg B Skull Base       Date:  2021-12-17

6.  Evaluation of Surgical Freedom for One-and-a-Half Nostril, Mononostril, and Binostril Endoscopic Endonasal Transsphenoidal Approaches.

Authors:  Jin Yang; Guodao Wen; Chao Tang; Chunyu Zhong; Junhao Zhu; Zixiang Cong; Chiyuan Ma
Journal:  J Neurol Surg B Skull Base       Date:  2020-02-28

Review 7.  Olfactory outcomes after endonasal skull base surgery: a systematic review.

Authors:  Junhao Zhu; Kaiyang Feng; Chao Tang; Jin Yang; Xiangming Cai; Chunyu Zhong; Chiyuan Ma
Journal:  Neurosurg Rev       Date:  2020-09-10       Impact factor: 3.042

8.  Quality of Life before and after Endoscopic Pituitary Surgery as Measured by the Short-Form-36.

Authors:  Edward C Kuan; Frederick Yoo; Jennifer Chyu; Angela Oh; Marvin Bergsneider; Marilene B Wang
Journal:  J Neurol Surg B Skull Base       Date:  2017-11-07

9.  One-and-a-half nostril endoscopic transsphenoidal approach for pituitary adenomas-a technical report.

Authors:  Guodao Wen; Chao Tang; Chunyu Zhong; Junyang Li; Zixiang Cong; Yuan Zhou; Kaidong Liu; Yong Zhang; Mamatemin Tohti; Chiyuan Ma
Journal:  J Otolaryngol Head Neck Surg       Date:  2016-11-15

10.  Impact of endoscopic endonasal pituitary surgery on nasal airway patency.

Authors:  Maryam Jalessi; Mohammad Farhadi; Alimohamad Asghari; Maryam Hosseini; Elahe Amini; Seyyed Behzad Pousti
Journal:  Med J Islam Repub Iran       Date:  2016-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.